Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Endocrinology

Diabetes Mellitus, Type 2

Alabama

Birmingham : Greystone Medical Research, LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Birmingham : Innovative Clinical Trials

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Birmingham : University of Alabama at Birmingham

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Birmingham : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Birmingham : Radiant Research - Birmingham

Clinical Research for Type 2 Diabetes

Birmingham : Radiant Research - Birmingham

Has your doctor told you your blood sugar level is not adequately controlled?

Birminghman : Greystone Medical Research, LLC

Type II Diabetes Research

Haleyville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Huntsville : Medical Affiliated Research Center, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Huntsville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Huntsville : Medical Affiliated Research Center, Inc.

Are you controlling your diabetes or is it controlling you?

Huntsville : Medical Affiliated Research Center, Inc.

From diagnosis to decision

Mobile : Mobile Diagnostic Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Mobile : Sunbelt Research Group

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Mobile : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Mobile : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Mongomery : HealthScan Research, LLC

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Montgomery : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Muscle Shoals : Terence T. Hart, MD

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Muscle Shoals : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Muscle Shoals : Terence T. Hart

Type II Diabetes Research

Pell City : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Tuscaloosa : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Arizona

Chandler : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Chandler : Clinical Research Advantage

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Chandler : Radiant Research - Phoenix, Southeast

Type 2 Diabetes Research Study (people not taking medications)

Chandler : Radiant Research - Phoenix, Southeast

Type 2 Diabetes Research Study (people taking Actos® or Avandia®)

Mesa : Clinical Research Advantage/Central Arizona Medical Associates

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Mesa : Clinical Research Advantage, Desert Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Peoria : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

Phoenix : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Phoenix : Clinical Research Advantage

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Phoenix : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Phoenix : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Phoenix : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Phoenix : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Phoenix : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Phoenix : Lovelace Scientific Resources, Inc.

Do you have high blood sugars?

Phoenix : Clinical Research Advantage, Inc

Type II Diabetes Research

Phoniex : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Scottsdale : Research Site:

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Tucson : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Tucson : Quality of Life Medical & Research Center, LLC

Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Arkansas

Harrisburg : Harrisburg Family Medical Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Harrisburg : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Hot Springs : Hot Springs Internal Medicine

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Hot Springs : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Hot Springs : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Jonesboro : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

Jonesboro : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Little Rock : Medical Investigations Inc.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Little Rock : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Mountain Home : North Central Arkansas Medical Associates

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

California

Anaheim : Orange County Clinical Trials, Inc.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Anaheim : Advanced Clinical Research Institute

High Blood Sugar Levels can affect Your Health.

Anaheim : Advanced Clinical Research Institute

Patients with type 2 diabetes needed for a clinical research trial.

Anaheim : Advanced Clinical Research Institute

Type II Diabetes Research

Artesia : Sall Research Medical Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Artesia : Sall Research Center

Type II Diabetes Research

Artesia : Precious Life Clinical Trials

Type II Diabetes Research

Bermuda Dunes : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Beverly Hills : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Buena Park : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Buena Park : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Buena Park : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Burbank : Providence Clinical Research

Is Diabetes a Part of Your Life?

Burbank : Providence Clinical Research

Type 2 Diabetes: Giving Medication a Try

Chino : Catalina Research Institute, LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Chino : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Chula Vista : Research Site:

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

Chula Vista : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Chula Vista : Research Site:

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

Concord : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Concord : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Costa Mesa : Clinical Innovations

Type 2 Diabetes Study for patients on Actos (proglitazone) only.

Cypress : Research Site:

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

Cypress : Research Site:

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

Cypress : West Coast Clinical Trials

Pediatric Type 2 Diabetes Study

Cypress : West Coast Clinical Trials

Type II Diabetes / Renal Impairment Research Study

Escondido : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Escondido : AMCR Institute, Inc.

A study to assess the effectiveness of PAP treatment on glycemic control (HbA1c) in patients with diabetes

Escondido : AMCR Institute, Inc.

A study to compare safety of an oral medication in Type 2 Diabetes patients

Escondido : AMCR Institute, Inc.

A study to evaluate the safety and efficacy of a medication at four dose levels in Diabetes Type 2 patients

Fountain Valley : Novellus Research Sites, Inc.

Clinical Research Study for People with Type 2 Diabetes

Fountain Valley : Novellus Research Sites, Inc. New!

Type 2 Diabetes Study that is evaluating the safety, efficacy and tolerability of the study drug, as an add-on treatment to Metformin (Glucophage), for the treatment of Type 2 Diabetes.

Fresno : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

Fresno : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Fresno : Universal Biopharma Research Institute Inc.

Type II Diabetes Research

Huntington Beach : Huntington Beach Hospital

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

La Jolla : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Lajolla : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Lancaster : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Loma Linda : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Loma Linda : DHARMA Health and Research Management

Do you have Type 2 Diabetes?

Long Beach : West Coast Clinical Trials

Do you have Type II Diabetes?

Long Beach : West Coast Clinical Trials

Do you have Type II Diabetes?

Los Angeles : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Los Angeles : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Los Angeles : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Los Angeles : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Los Angeles : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Los Angeles : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Los Angeles : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Los Banos : KD Medical Group, Inc

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Los Banos : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Mission Hills : Facey Medical Foundation

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Mission Hills : Facey Medical Foundation

Type II Diabetes Research

Mission Viejo : Mission Internal Medical Group

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Mission Viejo : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Mission Viejo : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Mission Viejo : Endocrine Research

Type II Diabetes Research

National City : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

National City : Synergy Clinical Research Center

Diabetes Type II

Northridge : Diabetes Medical Center of CA

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Norwalk : Lucia M. Cruz, MD., Inc.

Type II Diabetes Research

Orange : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Palm Springs : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Palm Springs : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Palm Springs : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Paramount : Center for Clinical Trials, LLC

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Petaluma : Research Center

Type II Diabetes Research

Rancho Cucamonga : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Rancho Cucamonga : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Rancho Cucamonga : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Redlands : Avastra Clinical Trials formerly Pacific Sleep Medicine Services, Inc. (Redlands)

Are you unable to Manage your Type 2 Diabetes with Diet and Exercise Alone?

Redlands : Avastra Clinical Trials formerly Pacific Sleep Medicine Services, Inc. (Redlands)

Are you unable to manage your Type 2 Diabetes?

Redlands : Anderson Clinical Research

Study of an investigational medication for the treatment of type 2 diabetes

Riverside : Clinical Innovations

Hypertension and Type 2 Diabetes Outpatient Study

Roseville : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Roseville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Roseville : Sutter Institute for Medical Research (SIMR)

Diabetes Type 2

Sacramento : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Sacramento : Sutter Institute for Medical Research (SIMR)

Diabetes Type 2

Salinas : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Salinas : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

San Diego : Scripps Clinic - Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

San Diego : Sharp Rees-Stealy Medical Group

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

San Diego : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

San Diego : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

San Diego : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

San Diego : Avastra Climical Trials formerly Pacific Sleep Medicine Services, Inc. (San Diego, CA)

Are you unable to Manage your Type 2 Diabetes with Diet and Exercise Alone?

San Diego : Wetlin Research Associates, Inc.

Type 2 Diabetes Study

San Leandro : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

San Mateo : Mills-Peninsula Health Services, Dorothy L. and James E. Frank Diabetes Research Institute

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Santa Ana : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Santa Ana : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Santa Ana : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Santa Ana : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Santa Ana : Apex Research Institute

Do You Have Type 2 Diabetes?

Santa Ana : Crest Clinical Trials, Inc

Type II Diabetes Research

Santa Monica : Coastal Biomedical Research Inc

Type II Diabetes Research

Spring Valley : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Stockton : St. Joseph's Medical Associates

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Tarzana : The Metabolic Institute of America

Type II Diabetes Research

Temecula : AMCR Institute, Inc.

A study to evaluate the efficacy of the study medication MK-0941 as an add on therapy to patients on long acting basal insulin.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Walnut Creek : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Walnut Creek : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Walnut Creek : Diablo Clinical Research

Can you tell me about the study drug?

Walnut Creek : Diablo Clinical Research

Diabetes Shouldn’t Define You

Walnut Creek : Diablo Clinical Research

Do you have type 2 diabetes?

Walnut Creek : Diablo Clinical Research

Do you have Type 2 Diabetes? Consider Volunteering?

Walnut Creek : Diablo Clinical Research

From diagnosis to decision. If you have type 2 diabetes there are a few things you should know

Walnut Creek : Diablo Clinical Research

Have you been diagnosed with Type II Diabetes?

Walnut Creek : Diablo Clinical Research

Raise your hand if you have type 2 diabetes

Walnut Creek : Diablo Clinical Research

When your type 2 diabetes is out of control, finding harmony is essential

Walnut Creek : Diablo Clinical Research

You may be eligible to join the EMERGE STUDY if you

West Hills : Infosphere Clinical Research, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

West Hills : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Colorado

Boulder : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Colorado Springs : ExpressCare Clinical Research

A study evaluating the effectiveness in treating Type 2 Diabetes with sitagliptin(Januvia) in combination with pioglitazone(Actos) in those who have inadequate glycemic control

Colorado Springs : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Colorado Springs : Research Center

Type II Diabetes Research

Longmont : Longmont Medical Research Network

DIABETES TYPE 2 RESEARCH STUDY

Longmont : Longmont Medical Research Network

TYPE II DIABETES RESEARCH STUDY

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Wheatridge : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Connecticut

Bridgeport : Bridgeport Hospital

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Hamden : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

New Britain : The Hospital of Central Connecticut

When your TYPE 2 DIABETES is out of control, finding harmony is essential.

New Britain : The Hospital of Central Connecticut

When your TYPE 2 DIABETES is out of control, finding harmony is essential.

Stamford : Stamford Therapeutics Consortium

TYPE 2 DIABETES Study -- The Power of Two

Trumbull : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Waterbury : Chase Medical Research, LLC

A Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide When Used in Combination with Metformin in Subjects with Type 2 Diabetes.

Waterbury : Chase Medical Research, LLC

A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus.

Delaware

Newark : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Wilmington : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Florida

Altomonte Springs : Central Florida Clinical Trials, Inc

Type II Diabetes Research

Bradenton : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Bradenton : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Brooksville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Chiefland : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Chiefland : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Chiefland : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Chiefland : Southeast Clinical Research

Type II Diabetes Research

Chipley : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Clearwater : Clinical Research of West Florida

16 Million People in the U.S. Have Type II Diabetes. Are You One of Them?

Clearwater : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Clearwater : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Clearwater : Clinical Research of West Florida, Inc.

Do you have type 2 diabetes?

Clearwater : Clinical Research of West Florida, Inc.

Type II Diabetes Research

Clearwater : Clinical Research of West Florida

Type II Diabetes Research

Clearwater : Florida Research & Testing

Type II Diabetes Research

Clearwater : Clinical Research of West Florida, Inc.

When your TYPE 2 DIABETES is out of control, finding harmony is essential.

Coral Gables : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Coral Gables : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Coral Gables : Clinical Research of South Florida New!

Do you have Diabetes?

Daytona Beach : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Daytona Beach : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Delray Beach : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Fort Lauderdale : Berma Research Group

Type II Diabetes Research

Fort Myers : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Ft. Lauderdale : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Ft. Myers : Research Site:

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

Gainesville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Green Cove Springs : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Green Cove Springs : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Hialeah : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Hollywood : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Hollywood : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Hollywood : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Jacksonville : Research Site:

A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and Class II Heart Failure.

Jacksonville : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

Jacksonville : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Jacksonville : Jacksonville Center For Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Jacksonville : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Jacksonville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Jacksonville : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Jacksonville : Research Center

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Jacksonville : Southeast Clinical Research LLC

Type II Diabetes Research

Kissimmee : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Largo : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Miami : Well Pharma Medical Research, Corp.

A 26 week randomized, multinational, open labelled, 2 armed, parallel group, treat-to-target once daily treatment trial with insulin detemir versus insulin glargine, both in combination with metformin in subjects with type 2 diabetes.

Miami : Well Pharma Medical Research, Corp.

A multi-center, randomized double-blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as monotherapy in patients with type 2 diabetes.

Miami : Well Pharma Medical Research, Corp.

A muti-center, randomized double blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as add-on therapy to metformin in patients with type 2 diabetes.

Miami : Well Pharma Medical Research, Corp.

A muti-center, randomized double blind study to evaluate the efficacy and long-term safety of vildagliptin modified release as add-on therapy to metformin in patients with type 2 diabetes.

Miami : Well Pharma Medical Research, Corp.

A phase 2 randomized two-stage open-label multi-center 24-week to evaluate the efficacy safety and tolerability of itca650 in subjects with type 2 diabetes mellitus

Miami : Well Pharma Medical Research, Corp.

A randomized double blind, placebo-controlled parallel-group multicenter 24-week study followed by an extension assessing the efficacy and safety of AVE0010 on top of metformin in patients with type 2 diabetes not adequately controlled with metformin.

Miami : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Miami : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Miami : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Miami : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Miami : Department of Research Tukoi Institute for Clincal Research

Type II Diabetes Research

Miami : Next Phase Clinical Trials, Inc

Type II Diabetes Research

Miramar : Research Site:

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

New Port Richey : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

New Port Richie : Suncoast Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

NewPort Richey : Suncoast Clinical Research, Inc

Type II Diabetes Research

NewPort Richey : Suncoast Clinical Research, Inc

Type II Diabetes Research

Ocala : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Ocala : Renstar Medical Research

Current treatment not controlling your Diabetes?

Ocala : Renstar Medical Research

Need help controlling your Type II Diabetes?

Ocala : Renstar Medical Research

Overweight with Type II Diabetes?

Ocala : Renstar Medical Research

Type II Diabetes that is not controlled by medication

Ocala : Renstar Medical Research

Uncontrolled Type II Diabetes`

Orlando : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Ormond Beach : Peninsula Research, Inc.

Type II Diabetes

Oviedo : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Oviedo : Alpha Medical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Oviedo : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Oviedo : Alpha Medical Research

Harmony, a Global Type 2 Diabetes Program

Oviedo : Alpha Medical Research

The GetGOAL-P Study to evaluate the effectiveness of an investigational medication for people with type 2 diabetes.

Panama City : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Panama City : Springfield Medical Center

Type II Diabetes Research

Pembroke Pines : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Pinellas Park : Radiant Research - St. Petersburg

Have you been diagnosed with TYPE 2 DIABETES?

Plantation : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Plantation : Berma Research Group

Type II Diabetes Research

Port Charlotte : Coastal Nephrology Assoc. Research Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Port Charlotte : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Saint Cloud : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Sebastian : Research Center

Type II Diabetes Research

St Petersburg : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

St. Petersburg : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Tallahassee : Southeastern Research Group, Inc.

A Phase III Clinical Trial to Evaluate the Effectiveness of a DPP-IV Inhibitor as Adjuvant Therapy for Achieving Glycemic Control in Patients with Type II Diabetes

Tallahassee : Southeastern Research Group, Inc.

Type II Diabetes - Inhaled Insulin for the Control of Blood Sugar

Tampa : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Tampa : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Tampa : Clinical Research of West Florida, Inc.

When your TYPE 2 DIABETES is out of control, finding harmony is essential.

Trinity : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Wellington : Clinicle Research Center LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

West Palm Beach : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Winter Park : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Georgia

Atlanta : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Atlanta : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Atlanta : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Atlanta : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Atlanta : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Atlanta : Radiant Research - Atlanta

Diabetes Research Study

Atlanta : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Augusta : Masters of Clinical Research, Inc.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Augusta : Masters of Clinical Research, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Augusta : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Blue Ridge : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Columbus : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Conyers : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Decatur : William C. McGarity Jr. MD, PC

Type II Diabetes Research

Jonesboro : Wellspring Medical Center

Type II Diabetes Research

Lilburn : Fellows Research Alliance Inc

Type II Diabetes Research

Rome : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Roswell : Endocrine Research Solutions, Inc.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Roswell : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Roswell : Endocrine Research Solutions, Inc.

Type 2 Diabetes

Suwanee : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Waycross : Waycross Internal Medicine

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Hawaii

Honolulu : Research Site:

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

Idaho

Boise : Northwest Clinical Trials, Inc.

A study for newly diagnosed Type 2 diabetics or diabetics for whom diet and exercise are no longer enough

Boise : Northwest Clinical Trials, Inc.

A study for people who have inadequately controlled Type 2 Diabetes

Hayden Lake : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Idaho Falls : Rocky Mountains Diabetes & Osteoporosis Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Idaho Falls : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Nampa : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Nampa : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Illinois

Addison : Provident Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Aurora : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Aurora : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Bloomingdale : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Chicago : Apex Medical Research, AMR, Inc.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Chicago : ICCT Research International, Inc.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Chicago : Associates in Internal Medicine

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Chicago : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Chicago : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Chicago : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Chicago : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Chicago : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Chicago : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Chicago : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Chicago : Apex Research of Riverside

Adult age 18-80 years with diabetes mellitus type 2 on metformin and pioglitazone.

Chicago : Apex Research of Riverside

Adults age 18-80 years with diabetes mellitus type 2 on metformin monotherapy or metformin in combination with a sulfonylurea.

Chicago : Adviso Medical Research

Type II Diabetes Research

La Grange Highlands : Robert J. Becker MD, LTD

Type II Diabetes Research

Libertyville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Lombard : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

O'Fallon : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Peoria : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Peoria : Knight Center for Integrated Health

Type II Diabetes Research

Peoria : Research Associates of Central Illinois

Type II Diabetes Research

Springfield : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Springfield : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Vernon Hills : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Vernon Hills : Westlake Medical Associates

Type II Diabetes Research

Indiana

Avon : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Avon : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Avon : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Evansville : MediSphere Medical Research Center, LLC

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Evansville : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Evansville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Evansville : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Evansville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Evansville : Welborn Clinic

Do You Have Type II Diabetes?

Fishers : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Indianapolis : American Health Network

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Indianapolis : Midwest Institute For Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Indianapolis : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Indianapolis : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

New Albany : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Iowa

Des Moines : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Iowa City : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Kansas

Arkansas City : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Kansas City : University of Kansas Medical Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Kansas City : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Lansing : Associates Research, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Topeka : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Wichita : Professional Research Network of Kansas

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Wichita : Wichita Clinic, PA

An Adult Type 2 Diabetic Study

Wichita : Wichita Clinic, PA

An Adult Type 2 Diabetic Study

Kentucky

Lexington : Kentucky Diabetes and Endocrinology

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Lexington : The Research Group of Lexington LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Lexington : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Lexington : University of Kentucky Chandler Medical Center New!

Diabetes: Do you have type 1 or type 2 diabetes? Or Do you have a relative with type 1 diabetes?

Lexington : University of Kentucky Chandler Medical Center New!

Diabetes: Have you recently been diagnosed with type 2 diabetes?

Madisonville : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Madisonville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Madisonville : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Munfordville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Louisiana

Baton Rouge : Stanacola Medical Center

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Baton Rouge : Pennington Biomedial Research Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Baton Rouge : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Deridder : Kufoy Medical Clinic

Type II Diabetes Research

Metairie : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Metairie : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

New Orleans : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

New Orleans : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Maine

Bangor : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Bangor : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Portland : Intermed

Type II Diabetes Research

Maryland

Baltimore : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Baltimore : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Baltimore : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Baltimore : Johns Hopkins Asthma& Allergy Center

Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.

Bethesda : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Bethesda : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Frederick : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Hagerstown : Johns Hopkins University

Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.

Oxon Hill : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Oxon Hill : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Oxon Hill : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Oxon Hill : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Parkville : Stephen Smith MD, FACP

Type II Diabetes Research

Rockville : Endocrine Metabolic Consultants

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Rockville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Massachusetts

Ayer : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Boston : Brigham and Women's Hospital and Joslin Diabetes Center

Do you have type 2 diabetes and are ready to stop struggling with your weight? Would you consider weight loss surgery OR be willing to participate in an intensive lifestyle program?

Boston : Joslin Diabetes Center

Seeking Volunteers ages 18-75 with Type 2 diabetes

Boston : Massachusetts General Hospital New!

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR MGH)

Boston : Brigham and Women's Hospital New!

The Role of the Mineralocorticoid Receptor in Diabetic Cardiovascular Disease

Dartmouth : Infinity Medical Research Inc

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Haverhill : ActivMed Practices & Research, Inc. New!

Currently Looking for Patients for a Type 2 Diabetes Trial

Springfield : Future Care Studies

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Waltham : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Michigan

Ann Arbor : ClinSite, LLC

Research Study for Type II Diabetes

Benzonia : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Buckley : Northern Pines Health Center

Type II Diabetes Research

Detroit : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Detroit : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Detroit : Livernois Family Medical Center

Type II Diabetes Research

Ferndale : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Ferndale : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Kalamazoo : Borgess Research Institute

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Kalamazoo : Borgess Research Institute

A study evaluating an investigational medication for type II diabetes.

Kalamazoo : Borgess Research Institute

A study evaluating an investigational medication for type II diabetes.

Kalamazoo : Borgess Research Institute

A study evaluating an investigational medication for type II diabetes.

Kalamazoo : Borgess Research Institute

A study evaluating an investigational medication for type II diabetes.

Kalamazoo : Borgess Research Institute

A study evaluating an investigational medication for type II diabetes.

Kalamazoo : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Kalamazoo : Borgess Research Institute

A study to evaluate the effectiveness of an investigational medication for people with type II diabetes.

Kalamazoo : Borgess Research Institute

A study to lower the risk of cardiovascular and renal health problem in type II diabetics.

Paw Paw : Beyer Research

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Royal Oak : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Royal Oak : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Southfield : Pearl Medical Group

Type II Diabetes Research

Troy : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Troy : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Minnesota

Brooklyn Park : Twin Cities Clinical Research

Do you have Type II Diabetes and Chronic Kidney Disease?

Eagan : MNCOME

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Edina : Radiant Research - Minneapolis New!

Do you take metformin for type 2 diabetes?

Edina : Radiant Research

Type 2 Diabetes Research Study Diet Controlled

Minneapolis : Fairview Pharmacy Services

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Minneapolis : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Minneapolis : Research Site:

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Minneapolis : International Diabetes Center

Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Mississippi

Biloxi : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Biloxi : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Jackson : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Olive Branch : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Olive Branch : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Olive Branch : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Olive Branch : Olive Branch Family Medical Center

Type II Diabetes Research

Picayune : Mississippi Medical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Picayune : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Missouri

Butte : Mercury Street Medical - Great Falls Clinic, LLP

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Florissant : Patterson Medical Clinic

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Jefferson City : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Kansas City : Dynamic Clinical Research, Inc.

A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to compare the safety and efficacy of Starlix (nateglinide) vs. placebo in patients with type 2 diabetes who are inadequately controlled with basal insulin glargine in combination with metformin and/or thiazolidinedione (pioglitazone or rosiglitazone)

Kansas City : Dynamic Clinical Research, Inc.

A Multi-center, Randomized, Open-label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment with Vildagliptin 100mg, qd to Thiazolidinedione (TZD) as Add-on Therapy in Patients with type 2 Diabetes Inadequately Controlled with Metformin Monotherapy in a Community-based Practice Setting

Kansas City : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Saint Louis : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

St Louis : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

St Louis : Clayton Medical Research

Type II Diabetes Research

St Peters : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

St. Louis : Saint Louis University

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Are you down in the dumps with your diabetes?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Pre-diabetes: Are you at risk?

St. Louis : St. Louis Medical Professionals, LLC

The durability of twice daily insulin lispro low mixture compared to once daily insulin Glargine when added to existing oral therapy in patients with type 2 diabetes and inadequate glycemic control.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Washington : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Montana

Billings : Billings Clinic Research Center

Are You a Type 2 Diabetic and Your Current Medications Are Just Not Enough?

Billings : Billings Clinic Research Center

Attention Type 2 Diabetics!

Billings : Montana Health Research Institute, Inc.

Do you have diabetes?

Billings : Billings Clinic Research Center

Do You Have Type 2 Diabetes? Are Diet and Exercise Not Working?

Butte : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Butte : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Nebraska

Grand Island : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

North Platte : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Omaha : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

Omaha : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Omaha : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Omaha : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Nevada

Henderson : Lovelace Scientific Resources - NV

Type 2 Diabetes

Las Vegas : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Las Vegas : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Las Vegas : AB Clinical Trials

DO YOU HAVE TYPE II DIABETES?

Las Vegas : Clinical Research Center of Nevada

When your TYPE 2 DIABETES is out of control, finding harmony is essential.

Pahrump : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Pahrump : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

New Hampshire

Concord : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Nashua : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

New Jersey

Berlin : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Berlin : Comprehensive Clinical Research

Type II Diabetes Research

Brick : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Camden : Virtua Family Health Center

Type II Diabetes Research

Elizabeth : Central Jersey Medical Research

Type II Diabetes Research

Neptune : MDS Pharma Services

Type 2 Diabetics

Passaic : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Ridgewood : The Valley Hospital

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Toms River : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Toms River : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Toms River : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Toms River : Physicians Research Center, LLC

Type 2 Diabetes

Trenton : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Trenton : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Voorhees : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Whitehouse : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

New Mexico

Albuquerque : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

New York

Albany : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Binghamton : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

Targeting Inflammation using Salsalate for Type 2 Diabetes -TINSAL T2D

Bronx : Biomedical Research Alliance of New York

Type 2 Diabetes Mellitus - Adults

Brooklyn : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Brooklyn : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Buffalo : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Hudson : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Lake Success : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Lake Success : Biomedical Research Alliance of New York

Clinical trial to test how different doses of a study drug can help people with Type 2 Diabetes

Manlius : Central New York Clinical Research

Are You Diabetic? Do You Have High Blood Pressure?

Mineola : Winthrop University Hospital Clinical Trials Center

DIABETES TYPE 2

New Hyde Park : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

New York : Mount Sinai Medical Center

A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU]

New York : Mount Sinai Medical Center

A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naive Patients with Type 2 Diabetes Mellitus [H7U-MC-IDAU]

New York : Mount Sinai Medical Center

A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients with Type 2 Diabetes Treated with Once-Daily Insulin Glargine [H7U-MC-IDBA]

New York : Weill Medical College of Cornell University

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

New York : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

New York : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

New York : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

New York : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

New York : Weill Cornell Medical College

Diabetes Study

New York : Clinilabs, Inc.

Recently Diagnosed with Diabetes?

New York : Clinilabs, Inc.

Suffering from Type II Diabetes?

New York : Mount Sinai Medical Center

The DURABLE Trial:
Assessing the DURAbility of Basal vs. Lispro Mix 25 Insulin Efficacy

The Durability of Twice-Daily Insulin Lispro Low Mixture
Compared to Once-Daily Insulin Glargine when
added to Existing Oral Therapy in Patients with Type 2 Diabetes and Inadequate Glycemic Control [F3Z-US-IOOV]

Oneida : Oneida Medical Associates

Type II Diabetes Research

Rochester : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Rochester : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Rochester : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Rochester : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Rochester : Rochester Clinical Research

Diabetes - Type2

Smithtown : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Springfield Gardens : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Springfield Gardens : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Staten Island : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Staten Island : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Staten Island : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Syracuse : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Syracuse : Internist Associates of Central New York, PC

Do you have high blood sugar?

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

West Seneca : Southgate Medical Group

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

West Seneca : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Westfield : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

North Carolina

Asheboro : Randolph Medical Association

Type II Diabetes Research

Burlington : Cornerstone Medical Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Calabash : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Cary : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Chapel Hill : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Charlotte : Sensenbrenner Primary Care

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Charlotte : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Charlotte : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Charlotte : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Charlotte : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Charlotte : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Charlotte : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Charlotte : Metrolina Medical Research

DIABETES Research Study

Charlotte : Metrolina Medical Research

DIABETES: Is Diabetes a Part of Your Life?

Durham : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Durham : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Durham : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Durham : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Fayetteville : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Fayetteville : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Greensboro : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Greensboro : Bland Clinic, PA

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Greensboro : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Harrisburg : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Hickory : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Hickory : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Hickory : Unifour Medical Research

DIABETES: Do you have Type 2 Diabetes?

Hickory : Unifour Medical Research

DIABETES: Do you have Type 2 Diabetes?

Hickory : Unifour Medical Research

DIABETES: Is metformin or metformin plus sulfonylurea the ONLY medication(s) you are taking for your diabetes?

Hickory : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

High Point : Peters Medical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Hunters Ville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Mooresville : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Mooresville : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Mooresville : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Raleigh : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Raleigh : Multi-Specialty Research Associates of NC

Are you a diabetic patient taking medicine to treat your high cholesterol?

Raleigh : Multi-Specialty Research Associates of NC

Are you on insulin and suffer from Type 2 diabetes?

Raleigh : Triangle Medical Research

DIABETES: Is Diabetes a Part of Your Life?

Raleigh : Multi-Specialty Research Associates of NC

Do you suffer from Type 2 diabetes?

Salisbury : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Salisbury : Crescent Medical Research

DIABETES Research Study

Salisbury : Crescent Medical Research

DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin

Shelby : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Statesville : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Statesville : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Statesville : Carolina Pharmaceutical Research

Type II Diabetes Research

Wilmington : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Wilmington : Wilmington Medical Research

DIABETES research volunteers needed

Wilmington : Wilmington Medical Research

DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin

Winston-Salem : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Winston-Salem : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Winston-Salem : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Winston-Salem : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Winston-Salem : Piedmont Medical Research

DIABETES (TYPE 2) Research Study

Winston-Salem : Piedmont Medical Research

DIABETES Research Study

Winston-Salem : Piedmont Medical Research

DIABETES Research Study

Winston-Salem : Piedmont Medical Research

DIABETES: Are you taking Metformin for your Type 2 Diabetes?

Winston-Salem : Piedmont Medical Research

DIABETES: Is metformin or metformin plus sulfonylurea the ONLY medication(s) you are taking for your diabetes?

Winston-Salem : Piedmont Medical Research

DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin

North Dakota

Bismarck : Family Medical Center North

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Bismarck : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Bismarck : Odyssey Research Services

A Type II Diabetes Research Study

Fargo : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Fargo : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Grand Forks : Altru Health System Research Center

Volunteers Needed for a Clinical Research Trial of an Investigational Medication.

Minot : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Ohio

Akron : Radiant Research - Akron

Are you a Type 2 Diabetic?

Athens : Ohio University College of Osteopathic Medicine

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Athens : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Canton : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Carlisle : Medical Frontiers

Type II Diabetes Research

Centerville : Valley Medical Primary Care

Type II Diabetes Research

Cincinnati : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Cincinnati : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Cincinnati : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Cincinnati : Community Research

Type 2 Diabetes

Cincinnati : Community Research

Type 2 Diabetes

Cincinnati : Community Research

Type 2 Diabetes

Cincinnati : Community Research

Type 2 Diabetes

Cleveland : Rapid Medical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Cleveland : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Cleveland : Rapid Medical Research

Type II Diabetes Research

Columbus : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Columbus : Columbus Clinical Research New!

Diabetes

Columbus : Parsons Avenue Medical Center

Type II Diabetes Research

Dayton : Charles Hanshaw, DO

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Dayton : Providence Health Partners - Center for Clinical Research

Type II Diabetes - Diet Controlled

Dayton : Providence Health Partners - Center for Clinical Research

Type II Diabetes on Single or Multiple Medications

Gallipolis : Holzer Clinic

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Kettering : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Kettering : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Kettering : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Mentor : Your Diabetes Endocrine Nutrition Group, LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Mentor : Your Diabetes Endocrine Nutrition Group LLC

Type II Diabetes Research

Mogadore : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Ohio : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Perrysbur : Clinical Research Source, Inc

Type II Diabetes Research

Springdale : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Springdale : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Westlake : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Zanesville : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Zanesville : Pharmacotherapy Research Associates, Inc

Type II Diabetes Research

Oklahoma

Norman : Lynn Institute of Norman

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Norman : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Norman : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Oklahoma City : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Oklahoma City : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Tulsa : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Tulsa : Vital Prospects Clinical Research Institute, P.C.

Have HIGH BLOOD PRESSURE and DIABETES TYPE II? We need your help in a study to evaluate the efficacy and safety of Aliskiren administered in combination with Valsartan versus Valsartan alone.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Oregon

Bend : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Bend : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Medford : Clinical Research Institute of Southern Oregon, P.C.

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Medford : Clinical Research Institute of Southern Oregon

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Medford : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Medford : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Medford : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Medford : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Medford : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Medford : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Medford : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Medford : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Portland : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Portland : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Portland : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Portland : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Portland : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Portland : Covance

Overweight? Type 2 Diabetes?

Portland : Radiant Research - Portland

Type 2 Diabetes Research Study

Portland : Oregon Clinical Research

Type II Diabetes Research

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Pennsylvania

Altoona : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Beaver : Tri State Medical Group

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Beaver : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Beaver : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Beaver : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Beaver : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Beaver : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Bensalem : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Carlisle : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Connellsville : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Danville : Geisinger Medical Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Hershey : The Penn State University Hershey Medical Center

Development of a Screening Test for Endometrial Hyperplasia in an At Risk Cohort

Levittown : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Levittown : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Melrose Park : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Morrisville : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Norristown : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Norristown : Pearl Clinical Research Inc

Type II Diabetes Research

Philadelphia : Philadelpia Health Associates Adult Medicine

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Philadelphia : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Philadelphia : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Philadelphia : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Philadelphia : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Philadelphia : Philadelphia Clinical Research, LLC

Are you overweight with type II diabetes?... You might qualify to participate in a new clinical study

Philadelphia : Eastwick Primary Care

Type II Diabetes Research

Pittsburgh : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Pottsville : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Red Lion : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

RedLion : Dairyland Medical Center

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Scranton : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Tipton : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Warminster : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Warminster : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Rhode Island

Cranston : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Cranston : New England Center for Clinical Research

Type II Diabetes Research

Johnston : Clinical Partners, LLC

Recently diagnosed with Type 2 diabetes?

Providence : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

South Carolina

Clemson : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Clinton : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Columbia : Columbia Clinical Research, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Columbia : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Greenville : Upstate Pharmaceutical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Greer : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Greer : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Greer : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Greer : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

High Point : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Mount Pleasant : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Mount Pleasant : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Mount Pleasant : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Mount Pleasant : Palmetto Medical Research

DIABETES: Type II Diabetes Research Study for people on Long Acting Insulin

Peak : Research Center

Type II Diabetes Research

Simpsonville : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Spartanburg : S. Carolina Pharmaceutical Research

One Year Study for Type 2 Diabetes

Taylors : Southeastern Research Associates, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Varnville : Community Research Partners

Type II Diabetes Research

Tennessee

Brentwood : InvestiClin Research

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Bristol : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Bristol : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Bristol : Tricities Medical Research

DIABETES Research Study

Chattanoog : University Diabetes & Endocrine Consultants

Type II Diabetes Research

Clarksville : Alpha Clinical Research, LLC

Frustrated with type 2 diabetes?

Cleveland : Scenic City Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Crossville : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Jackson : Apex Cardiology

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Johnson City : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Johnson City : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Kingsport : Holston Medical Group

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Kingsport : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Kingsport : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Memphis : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Memphis : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Nashville : Dial Research Associates, Inc.

Clinical trial to evaluate an investigational type 2 oral diabetes medication compared to a marketed diabetes medication.

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Texas

Austin : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Austin : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Austin : Benchmark Research - Austin

Is Type 2 Diabetes a Part of Your Life?

Austin : Covance

Type 2 Diabetes?

Bellaire : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Dallas : Dallas Diabetes and Endocrine Research Center

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

Dallas : Baylor Research Institute

A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of taspoglutide (RO5073031) compared to placebo in obese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy

Dallas : Baylor Research Institute

A randomized, double-blind, placebo-controlled, 2-arm parallel-group, multicenter study with a 24-week main treatment period and an extension assessing the efficacy and safety of AVE0010 on top of pioglitazone in patients with type 2 diabetes not adequately controlled with pioglitazone.

Dallas : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Dallas : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Dallas : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Dallas : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Dallas : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Dallas : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Dallas : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Dallas : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Dallas : Radiant Research - Dallas, North

Diabetes (Type 2) Research

Dallas : Radiant Research - Dallas North

Diabetes Research: Inhaled Insulin

Dallas : KRK Medical Research

Do you have uncontrolled type 2 diabetes and currently taking oral medications or using diet and exercise?

Dallas : KRK Medical Research

Do you or someone you know suffer from Diabetes Type II?

Dallas : Radiant Research - Dallas, North

Type 2 Diabetes Research

Dallas : Dallas Diabetes and Endocrine Center

Type II Diabetes Research

Dallas : Galenos Research

When your Type 2 Diabetes is out of control, finding harmony is essential

Fort Worth : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Fort Worth : Benchmark Research - Fort Worth

Is Type 2 Diabetes a Part of Your Life?

Houston : Jacon Medical Research Associates

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Houston : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Houston : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Houston : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Houston : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Houston : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Houston : DynaMed Clinical Research

Type 2 Diabetes (ages 65+) - Houston, TX

Houston : Clinical Trial Network

Type II Diabetes Research

Hurst : Protenium Clinical Resarch, LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Irving : Bexar Clinical Trials LLC

Type II Diabetes Research

Lake Jackson : R/D Clinical Research, Inc.

Type 2 Diabetes Research Study

Lake Jackson : R/D Clinical Research, Inc.

Type 2 Diabetes Research Study

Mesquite : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Midland : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

Midland : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Midland : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Midland : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Midland : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Midland : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Midland : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

North Richland Hills : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

North Richland Hills : North Hills Family Practice

Type II Diabetes Research

Odessa : Naidu Clinic

Type II Diabetes Research

San Antonio : Cetero Research-San Antonio

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

San Antonio : Clinical Trials of Texas, Inc.

A 4-Week, Multicenter, Randomized, Double-Blind, Phase 3b Trial to Evaluate the Efficacy of Saxagliptin in Combination With Metformin XR 1500 mg Versus Uptitrated Metformin XR to 2000 mg in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise and a Stable Dose of Metformin XR 1500 mg

San Antonio : Research Site:

A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.

San Antonio : Research Site:

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

San Antonio : Research Site:

A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

San Antonio : Oakwell Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

San Antonio : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

San Antonio : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

San Antonio : Research Site:

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

San Antonio : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

San Antonio : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

San Antonio : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

San Antonio : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

San Antonio : Research Site:

A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.

San Antonio : Research Site:

A Study with RO5095932 in patients with type 2 diabetes on stable metformin therapy.

San Antonio : Cetero Research

Do you have Type 2 Diabetes? Are you tired? The GLYCOSA Study is assessing the effectiveness of Positive Airway Pressure (PAP) for glucose control in patients with Type 2 Diabetes Mellitus and Sleep Apnea.

San Antonio : Clinical Trials of Texas, Inc.

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

San Antonio : Sun Research Institute

Someday, instead of thinking and Diabetes medication every day of the week, it might only have to be one day.

San Antonio : Radiant Research - San Antonio

To Your Good Health! Especially for You!

San Antonio : Radiant Research - San Antonio

Type 2 Diabetes Research Study

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Utah

Clinton : Westside Medical

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Midvale : Avastra Clinical Trials (Midvale)

Are you unable to manage your Type 2 Diabetes with diet and exercise alone? You may be eligible to participate in a clinical research study.

Midvale : Avastra Clinical Trials (Midvale)

If you have Type 2 Diabetes, and are between 18 and 80 years of age, and are currently treated with metformin, you may qualify to participate.

Midvale : Avastra Clinical Trials (Midvale)

Raise your hand if you have Type 2 Diabetes!

Salt Lake City : Optimum Clinical Research, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Salt Lake City : Radiant Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Salt Lake City : Utah Clinical Trials, LLC

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Salt Lake City : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Salt Lake City : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Salt Lake City : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Salt Lake City : Optimum Clinical Research, Inc.

Are you having a hard time controlling your Diabetes?

Salt Lake City : Optimum Clinical Research, Inc.

Diabetes Type 2: Could you have type 2 diabetes?

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

West Valley City : Granger Medical Research

Type II Diabetes- Patients currently taking Metformin

Vermont

South Burlington : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Virginia

Abingdon : Research Site:

Episodic intensive blood glucose monitoring in non-insulin treated type 2 diabetes.

Arlington : Millennium Clinical Trials, L.L.C.

Diabetes

Burke : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Charlottesville : University of Virginia

Are you dealing with 'Sugar' (Diabetes)?

Charlottesville : University of Virginia

Volunteers 22-64 with DM2 needed for Kidney Study

Hampton : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Manassas : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Norfolk : Medical Consultants of Virginia Ltd

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Norfolk : York Clinical Research, Inc.

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Richmond : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Richmond : Research Site:

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Richmond : Richmond Family Practice

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Richmond : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Richmond : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Richmond : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Richmond : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Richmond : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Richmond : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Richmond : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Virginia Beach : Virginia Beach Family Practice

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Winchester : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Washington

Bellevue : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Everett : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Federal Way : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Federal Way : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Federal Way : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Renton : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Renton : Research Site:

A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairmant

Renton : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Renton : Rainier Clinical Research Center, Inc.

Are You Taking Insulin Shots or a Combination of Pills and Insulin Shots for Treatment of Type 2 Diabetes?

Renton : Rainier Clinical Research Center, Inc.

Diabetes: Inhaled Insulin Research

Renton : Rainier Clinical Research Center, Inc.

Diabetes: Are you taking ACTOS (pioglitazone) or AVANDIA (rosiglitazone) for Type 2 Diabetes?

Spokane : The Physicians Clinic of Spokane

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Spokane : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Spokane : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Tacoma : Research Site:

A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

Tacoma : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Tacoma : Charles River Clinical Services Northwest

Research Study (#08186) Type 2 Diabetes

Tacoma : Charles River Clinical Services Northwest

Research Study (#09060) Type 2 diabetes

Vancouver : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Various Cities : Research Center New!

Diabetes Study CLCQ908A2203

Washington, DC

Washington : Medstar Clinical Research

A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted.

Washington : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Washington : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Washington : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

West Virginia

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Wisconsin

Menomonee Falls : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Various Cities : Research Center New!

ALTITUDE Diabetes Study CSPP100E2337

Argentina

Buenos Aires : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Australia

Adelaide : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Adelaide : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Adelaide : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Adelaide : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Adelaide : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Adelaide : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Adelaide : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Camperdown : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Camperdown : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Canberra : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Freemantle : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Heidelberg : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Heidelberg : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

St. Leonards : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

St. Leonards : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

St. Leonards : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Sydney : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Sydney : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Sydney : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Sydney : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Sydney : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Sydney : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Wollongong : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Belgium

Antwerpen : Research Site:

A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.

Brazil

Belem - Pa : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Belo Horizonte : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Brasilia : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Brasilia : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Curitiba : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Forlateza : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Forlateza : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Fortaleza : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Fortaleza - Ce : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Fortaleza - Ce : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Goiania - Go : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Goiania - Go : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Marilia : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Mogi Das Cruzes - Sp : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Mogi Das Cruzes - Sp : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Passo Fundo : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Porto Alegre : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Porto Alegre : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Porto Alegre - Rs : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Porto Alegre - Rs : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Recife : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Sao Paulo : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Sao Paulo : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Sao Paulo : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Sao Paulo : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Sao Paulo : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Sorocaba : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Bulgaria

Dimitrovgrad : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Dimitrovgrad : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Pleven : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Pleven : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Ruse : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Ruse : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Ruse : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Sofia : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Sofia : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Sofia : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Varna : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Canada

Edmonton, AB : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Etobicoke, ON : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Etobicoke, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Halifax, NS : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Hamilton, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Hamilton, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Hamilton, ON : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

London, ON : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

London, ON : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

London, ON : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

London, ON : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

London, ON : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

London, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Montreal, QC : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Montreal, QC : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Montreal, QC : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Montreal, QC : Research Site:

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Mount Pearl : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Oakville, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Pointe-Claire, QC : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Pointe-Claire, QC : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Sherbrooke, NS : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Sherbrooke, QC : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Thornhill, ON : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Thornhill, ON : Research Site:

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Toronto, ON : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Toronto, ON : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Toronto, ON : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Toronto, ON : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Toronto, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Toronto, ON : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Toronto, ON : Research Site:

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Vancouver, BC : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Vancouver, BC : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Vancouver, BC : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Vancouver, BC : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Vancouver, BC : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Vancouver, BC : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Winnipeg, MB : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

China

Hong Kong : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Hong Kong : Research Site:

A Study of Aleglitazar in Patients With Type 2 Diabetes

Hong Kong : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Costa Rica

San Jose : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

San Jose : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Croatia

Zagreb : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Czech Republic

Havirov : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Denmark

Ballerup : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Ballerup : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Hvidovre : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Vejle : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Estonia

Paide : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Saku : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Tallinn : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Tartu : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Tartu : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Voru : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Finland

Helsinki : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Kuopio : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Oulu : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Tampere : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Turku : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

France

Amiens : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Besancon : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Besancon : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Bondy : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Corbeil-Essonnes : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Corbeil-Essonnes : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Corbeil-Essonnes : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Dijon : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Dommartin-Les-Toul : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Dommartin-Les-Toul : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

La Rochelle : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Lille : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Montpellier : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Nantes : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Narbonne : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Narbonne : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Narbonne : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Paris : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Paris : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Poitiers : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Poitiers : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Strasbourg : Research Site:

A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes

Venissieux : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Germany

Aschaffenburg : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Aschaffenburg : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Bad Lauterberg : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Bad Lauterberg : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Bammental : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Berlin : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Berlin : Research Site:

A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.

Berlin : Research Site:

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

Berlin : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Berlin : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Berlin : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Berlin : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Berlin : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Berlin : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Berlin : Research Site:

A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes

Berlin : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Berlin : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Bochum : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Damme : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Dortmund : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Dresden : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Dresden : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Dresden : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Essen : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Essen : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Essen : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Essen : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Falkensee : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Falkensee : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Falkensee : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Falkensee : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Falkensee : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Giessen : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Giessen : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Görlitz : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Görlitz : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Görlitz : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Görlitz : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Hamburg : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Hamburg : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Hannover : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Karlsruhe : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Kuenzing : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Ludwigshafen : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Luebeck : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Mainz : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Mainz : Research Site:

A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.

Mainz : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Mainz : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Mainz : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Mainz : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Mainz : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Mainz : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Mannheim : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

München : Research Site:

A Drug-Drug Interaction Study of GK Activator (2) and Ethanol in Patients With Type 2 Diabetes.

München : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

München : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Munster : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Munster : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Munster : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Münster : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Münster : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Münster : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Neuss : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Neuss : Research Site:

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

Neuss : Research Site:

A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

Neuss : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Neuss : Research Site:

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Neuss : Research Site:

A Study of Taspoglutide in Type 2 Diabetic Patients

Neuss : Research Site:

A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes

Neuss : Research Site:

A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.

Neuss : Research Site:

A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Neuwied : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Neuwied : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Neuwied : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Nürnberg : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Nürnberg : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Nürnberg : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Nürnberg : Research Site:

A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Pirna : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Potsdam : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Rhaunen : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Rodgau : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Siegen : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Sulzbach-Rosenberg : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Tann : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Villingen-Schwenningen : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Wangen : Research Site:

A Study of Taspoglutide versus Pioglitazone in Patients With Type 2 Diabetes

Zwenkau : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Greece

Thessaloniki : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Guatemala

Guatemala : Research Site:

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Guatemala : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.

Guatemala : Research Site:

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Guatemala City : Research Site:

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Guatemala City : Research Site:

A Study of DPP-IV (3) in Patients With Type 2 Diabetes.

Guatemala City : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Hong Kong

Hong Kong : Research Site:

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Hong Kong : Research Site:

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Hungary

Balatonfuered : Research Site:

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

Budapest : Research Site:

A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.

Budapest : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Budapest : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Debrecen : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Gyor : Research Site:

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus

Gyula : Research Site:

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Hodmezovasarhely : Research Site:

A Study